Annexon, Inc. (ANNX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $32k
- Mar 2 · No plan
- Form 4 sales
- 54
- On record
- Form 144 notices
- 44
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualMar 2, 2026 2026
Sold 5,565 shares at $5.42 ($30k)
Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 3.2% of holdings ($955k position)170,700 shares left3.1x usual sizeFollows a Form 144Filing
- 2 Form 4 saleNo planMar 2, 2026 same day
Sold 5,820 shares at $5.43 ($32k)
Dananberg Jamie, CHIEF MEDICAL OFFICER
No 10b5-1 planSold 4.5% of holdings ($703k position)123,582 shares leftFollows a Form 144Filing
- 3 Form 4 saleUnusualMar 2, 2026 same day
Sold 4,339 shares at $5.42 ($24k)
Overdorf Michael, EVP & CHIEF BUSINESS OFFICER
No 10b5-1 planSold 2.3% of holdings ($1M position)182,625 shares left3x usual sizeFollows a Form 144Filing
- 4 Form 4 saleNo planMar 2, 2026 same day
Sold 5,566 shares at $5.42 ($30k)
Yednock Ted, EVP & CHIEF INNOVATION OFFICER
No 10b5-1 planSold 3.5% of holdings ($866k position)154,161 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 4 saleNo planMar 2, 2026 same day
Sold 5,894 shares at $5.43 ($32k)
Artis Dean Richard, EVP & CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 3.2% of holdings ($1M position)180,093 shares leftFollows a Form 144Filing
- 6 Form 144 noticeNoticeJul 14, 2026 +134 days
Filed to sell 1,000 shares ($6k)
Wiggans Thomas G, Former Director
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 noticeNoticeJul 15, 2026 +1 day
Filed to sell 2,000 shares ($13k)
Wiggans Thomas G, Former Director
No 10b5-1 planFirst sale on recordFiling
- 8 Form 144 noticeNoticeAug 13, 2026 +29 days
Filed to sell 2,000 shares ($11k)
Wiggans Thomas G, Former Director
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (98)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Aug 13, 2026 | Wiggans Thomas G | Former Director | Form 144 notice | 2,000 | $11k | Notice | SEC | |
| Jul 15, 2026 | Jul 15, 2026 | Wiggans Thomas G | Former Director | Form 144 notice | 2,000 | $13k | Notice | SEC | |
| Jul 14, 2026 | Jul 14, 2026 | Wiggans Thomas G | Former Director | Form 144 notice | 1,000 | $6k | Notice | SEC | |
| Mar 2, 2026 | Mar 4, 2026 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,894 | $32k | 3.2% | No plan | SEC |
| Mar 2, 2026 | Mar 4, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 5,566 | $30k | 3.5% | No plan | SEC |
| Mar 2, 2026 | Mar 4, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 4,339 | $24k | 2.3% | Unusual | SEC |
| Mar 2, 2026 | Mar 4, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Form 4 sale | 5,820 | $32k | 4.5% | No plan | SEC |
| Mar 2, 2026 | Mar 4, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 5,565 | $30k | 3.2% | Unusual | SEC |
| Mar 2, 2026 | Mar 2, 2026 | Yednock Ted | Officer | Form 144 notice | 5,566 | $30k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | Artis Dean Richard | Officer | Form 144 notice | 5,894 | $32k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | Overdorf Michael | Officer | Form 144 notice | 4,339 | $24k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | Dananberg Jamie | Officer | Form 144 notice | 5,820 | $32k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | Lew Jennifer | Officer | Form 144 notice | 5,565 | $30k | Notice | SEC | |
| Feb 18, 2026 | Feb 20, 2026 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,290 | $27k | 4.1% | No plan | SEC |
| Feb 18, 2026 | Feb 20, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 7,857 | $40k | 7.5% | No plan | SEC |
| Feb 18, 2026 | Feb 20, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 6,225 | $32k | 4.8% | Unusual | SEC |
| Feb 18, 2026 | Feb 20, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Form 4 sale | 5,290 | $27k | 6.7% | No plan | SEC |
| Feb 18, 2026 | Feb 20, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 7,851 | $40k | 6.5% | Unusual | SEC |
| Feb 18, 2026 | Feb 18, 2026 | Lew Jennifer | Officer | Form 144 notice | 7,851 | $40k | Notice | SEC | |
| Feb 18, 2026 | Feb 18, 2026 | Artis Dean Richard | Officer | Form 144 notice | 5,290 | $27k | Notice | SEC | |
| Feb 18, 2026 | Feb 18, 2026 | Yednock Ted | Officer | Form 144 notice | 7,857 | $40k | Notice | SEC | |
| Feb 18, 2026 | Feb 18, 2026 | Overdorf Michael | Officer | Form 144 notice | 6,225 | $32k | Notice | SEC | |
| Feb 18, 2026 | Feb 18, 2026 | Dananberg Jamie | Officer | Form 144 notice | 5,290 | $27k | Notice | SEC | |
| Jul 14, 2025 | Jul 16, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 1,116 | $3k | 1.1% | No plan | SEC |
| Jul 14, 2025 | Jul 16, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,117 | $3k | 0.9% | No plan | SEC |
| Jul 14, 2025 | Jul 16, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 853 | $2k | 0.6% | No plan | SEC |
| Jul 14, 2025 | Jul 14, 2025 | Yednock Ted | Officer | Form 144 notice | 1,116 | $3k | Notice | SEC | |
| Jul 14, 2025 | Jul 14, 2025 | Overdorf Michael | Officer | Form 144 notice | 853 | $2k | Notice | SEC | |
| Jul 14, 2025 | Jul 14, 2025 | Lew Jennifer | Officer | Form 144 notice | 1,117 | $3k | Notice | SEC | |
| Feb 18, 2025 | Feb 20, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Form 4 sale | 5,521 | $16k | 14.2% | No plan | SEC |
| Feb 18, 2025 | Feb 20, 2025 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,515 | $16k | 6.2% | No plan | SEC |
| Feb 18, 2025 | Feb 20, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 8,345 | $24k | 12.0% | No plan | SEC |
| Feb 18, 2025 | Feb 20, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 6,618 | $20k | 7.1% | Unusual | SEC |
| Feb 18, 2025 | Feb 20, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 6,912 | $20k | 8.2% | Unusual | SEC |
| Feb 18, 2025 | Feb 18, 2025 | Yednock Ted | Officer | Form 144 notice | 8,345 | $24k | Notice | SEC | |
| Feb 18, 2025 | Feb 18, 2025 | Lew Jennifer | Officer | Form 144 notice | 8,338 | $24k | Notice | SEC | |
| Feb 18, 2025 | Feb 18, 2025 | Artis Dean Richard | Officer | Form 144 notice | 5,515 | $16k | Notice | SEC | |
| Feb 18, 2025 | Feb 18, 2025 | Dananberg Jamie | Officer | Form 144 notice | 5,521 | $16k | Notice | SEC | |
| Feb 18, 2025 | Feb 18, 2025 | Overdorf Michael | Officer | Form 144 notice | 6,618 | $20k | Notice | SEC | |
| Feb 13, 2025 | Feb 18, 2025 | Love Douglas | PRESIDENT AND CEO | Form 4 sale | 5,021 | $15k | 1.4% | No plan | SEC |
| Feb 13, 2025 | Feb 18, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,786 | $5k | 2.1% | No plan | SEC |
| Feb 13, 2025 | Feb 18, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 1,783 | $5k | 2.5% | No plan | SEC |
| Feb 13, 2025 | Feb 18, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 1,425 | $4k | 1.5% | No plan | SEC |
| Feb 13, 2025 | Feb 13, 2025 | Yednock Ted | Officer | Form 144 notice | 1,783 | $5k | Notice | SEC | |
| Feb 13, 2025 | Feb 13, 2025 | Love Douglas | Officer, Director | Form 144 notice | 5,021 | $15k | Notice | SEC | |
| Feb 13, 2025 | Feb 13, 2025 | Lew Jennifer | Officer | Form 144 notice | 1,786 | $5k | Notice | SEC | |
| Feb 13, 2025 | Feb 13, 2025 | Overdorf Michael | Officer | Form 144 notice | 1,425 | $4k | Notice | SEC | |
| Oct 15, 2024 | Oct 17, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 5,408 | $40k | 7.0% | Routine | SEC |
| Oct 15, 2024 | Oct 15, 2024 | Yednock Ted | Officer | Form 144 notice | 5,408 | $40k | Notice | SEC | |
| Sep 19, 2024 | Sep 20, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 4,500 | $32k | 100.0% | Routine | SEC |
| Sep 19, 2024 | Sep 19, 2024 | Yednock Ted | Officer | Form 144 notice | 4,500 | $32k | Notice | SEC | |
| Sep 12, 2024 | Sep 16, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 5,500 | $34k | 55.0% | Routine | SEC |
| Sep 12, 2024 | Sep 12, 2024 | Yednock Ted | Officer | Form 144 notice | 5,500 | $34k | Notice | SEC | |
| Sep 5, 2024 | Sep 6, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 5,500 | $31k | 35.5% | Routine | SEC |
| Sep 5, 2024 | Sep 5, 2024 | Yednock Ted | Officer | Form 144 notice | 5,500 | $31k | Notice | SEC | |
| Aug 29, 2024 | Aug 30, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 5,500 | $33k | 26.2% | Routine | SEC |
| Aug 29, 2024 | Aug 29, 2024 | Yednock Ted | Officer | Form 144 notice | 5,500 | $33k | Notice | SEC | |
| Jul 15, 2024 | Jul 17, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 784 | $5k | 0.8% | No plan | SEC |
| Jul 15, 2024 | Jul 17, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,104 | $7k | 1.3% | No plan | SEC |
| Jul 15, 2024 | Jul 17, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 1,106 | $7k | 1.5% | No plan | SEC |
| Jul 15, 2024 | Jul 15, 2024 | Overdorf Michael | Officer | Form 144 notice | 784 | $5k | Notice | SEC | |
| Jul 15, 2024 | Jul 15, 2024 | Yednock Ted | Officer | Form 144 notice | 1,106 | $7k | Notice | SEC | |
| Jul 15, 2024 | Jul 15, 2024 | Lew Jennifer | Officer | Form 144 notice | 1,104 | $7k | Notice | SEC | |
| Feb 20, 2024 | Feb 21, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 2,604 | $14k | 3.5% | No plan | SEC |
| Feb 20, 2024 | Feb 21, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 1,951 | $11k | 2.2% | No plan | SEC |
| Feb 20, 2024 | Feb 21, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 2,593 | $14k | 3.1% | No plan | SEC |
| Feb 20, 2024 | Feb 20, 2024 | Yednock Ted | Officer | Form 144 notice | 2,604 | $14k | Notice | SEC | |
| Feb 20, 2024 | Feb 20, 2024 | Lew Jennifer | Officer | Form 144 notice | 2,593 | $14k | Notice | SEC | |
| Feb 20, 2024 | Feb 20, 2024 | Overdorf Michael | Officer | Form 144 notice | 1,951 | $11k | Notice | SEC | |
| Feb 12, 2024 | Feb 14, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Form 4 sale | 1,349 | $7k | 2.7% | No plan | SEC |
| Feb 12, 2024 | Feb 14, 2024 | Love Douglas | PRESIDENT AND CEO | Form 4 sale | 5,782 | $32k | 2.9% | No plan | SEC |
| Feb 12, 2024 | Feb 14, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Form 4 sale | 1,809 | $10k | 3.8% | No plan | SEC |
| Feb 12, 2024 | Feb 14, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Form 4 sale | 1,810 | $10k | 4.8% | No plan | SEC |
| Feb 12, 2024 | Feb 12, 2024 | Overdorf Michael | Officer | Form 144 notice | 1,349 | $7k | Notice | SEC | |
| Feb 12, 2024 | Feb 12, 2024 | Love Douglas | Officer, Director | Form 144 notice | 5,782 | $32k | Notice | SEC | |
| Feb 12, 2024 | Feb 12, 2024 | Lew Jennifer | Officer | Form 144 notice | 1,809 | $10k | Notice | SEC | |
| Feb 12, 2024 | Feb 12, 2024 | Yednock Ted | Officer | Form 144 notice | 1,810 | $10k | Notice | SEC | |
| Dec 27, 2023 | Dec 29, 2023 | Yednock Ted | EVP & Chief Innovation Officer | Form 4 sale | 21,000 | $95k | 100.0% | Routine | SEC |
| Dec 27, 2023 | Dec 27, 2023 | Yednock Ted | Officer | Form 144 notice | 21,000 | $95k | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | Lew Jennifer | Officer | Form 144 notice | 1,057 | $4k | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | Yednock Ted | Officer | Form 144 notice | 1,057 | $4k | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | Overdorf Michael | Officer | Form 144 notice | 978 | $4k | Notice | SEC | |
| Jul 11, 2023 | Jan 23, 2024 | Overdorf Michael | EVP & Chief Business Officer | Form 4 sale | 978 | $4k | 2.1% | No plan | SEC |
| Jul 11, 2023 | Jan 23, 2024 | Lew Jennifer | EVP & Chief Financial Officer | Form 4 sale | 1,057 | $4k | 2.2% | No plan | SEC |
| Feb 15, 2023 | Feb 17, 2023 | Love Douglas | President & CEO | Form 4 sale | 6,571 | $39k | 3.2% | Plan not stated | SEC |
| Feb 14, 2023 | Feb 15, 2023 | Overdorf Michael | EVP & Chief Business Officer | Form 4 sale | 1,645 | $10k | 5.6% | Plan not stated | SEC |
| Feb 14, 2023 | Feb 15, 2023 | Lew Jennifer | EVP & Chief Financial Officer | Form 4 sale | 1,908 | $12k | 6.1% | Plan not stated | SEC |
| Sep 16, 2021 | Sep 20, 2021 | Love Douglas | President & CEO | Form 4 sale | 7,500 | $165k | 100.0% | Unusual | SEC |
| Sep 13, 2021 | Sep 15, 2021 | Yednock Ted | EVP & Chief Scientific Officer | Form 4 sale | 16,190 | $324k | 100.0% | Unusual | SEC |
| Sep 13, 2021 | Sep 15, 2021 | Lew Jennifer | EVP & Chief Financial Officer | Form 4 sale | 3,500 | $70k | 63.6% | Unusual | SEC |
| Jun 8, 2021 | Jun 9, 2021 | Love Douglas | President & CEO | Form 4 sale | 7,500 | $168k | 100.0% | Unusual | SEC |
| Jun 3, 2021 | Jun 7, 2021 | Yednock Ted | EVP & Chief Scientific Officer | Form 4 sale | 15,000 | $322k | 100.0% | Unusual | SEC |
| May 27, 2021 | Jun 1, 2021 | Lew Jennifer | EVP & Chief Financial Officer | Form 4 sale | 3,500 | $78k | 63.6% | Unusual | SEC |
| Apr 1, 2021 | Apr 2, 2021 | Love Douglas | President & CEO | Form 4 sale | 7,602 | $214k | 100.0% | Unusual | SEC |
| Mar 30, 2021 | Mar 31, 2021 | Love Douglas | President & CEO | Form 4 sale | 7,500 | $187k | 100.0% | Unusual | SEC |
| Mar 25, 2021 | Mar 29, 2021 | Yednock Ted | EVP & Chief Scientific Officer | Form 4 sale | 16,175 | $466k | 100.0% | Unusual | SEC |
| Mar 24, 2021 | Mar 26, 2021 | Keswani Sanjay | EVP & Chief Medical Officer | Form 4 sale | 3,995 | $121k | 100.0% | Unusual | SEC |
| Mar 23, 2021 | Mar 25, 2021 | Lew Jennifer | EVP & Chief Financial Officer | Form 4 sale | 5,000 | $142k | 71.4% | Unusual | SEC |